Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)

China flag China · Delayed Price · Currency is CNY
66.42
+0.23 (0.35%)
Feb 13, 2026, 3:04 PM CST
Market Cap17.60B +108.2%
Revenue (ttm)1.47B +10.8%
Net Income123.17M -5.5%
EPS0.47 -4.4%
Shares Out264.98M
PE Ratio141.37
Forward PE93.55
Dividendn/a
Ex-Dividend Daten/a
Volume3,761,957
Average Volume5,672,777
Open66.00
Previous Close66.19
Day's Range65.70 - 67.87
52-Week Range26.61 - 90.68
Beta-0.38
RSI39.51
Earnings DateMar 25, 2026

About SHE:300049

Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. The company operates in two segments: pharmaceutical production and sales; and diagnostic equipment R&D, production and sales. The pharmaceutical production and sales segment produces and sells products, such as Fufang Biejiaruangan tablets and shell fat capsules. The diagnostic equipment R&D, production and sales segment develops, produces, and sells the FibroScan series of liver fibrosis diagnostic instrument... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 867
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300049
Full Company Profile

Financial Performance

In 2024, SHE:300049's revenue was 1.35 billion, an increase of 16.93% compared to the previous year's 1.15 billion. Earnings were 113.29 million, an increase of 11.54%.

Financial Statements